- Galderma gets CRL for anti-wrinkle drug; Kimball buys CDMO for $103MPlus more from Lonza, Icosagen and others. 🟥 Galderma’s CRL: Galderma has received a complete response letter from the FDA for its relabotulinumtoxinA, a drug being reviewed as a neuromodulator…Endpoints · 25d ago↗ source
- STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and moreU.S. judge blocked a Colorado state panel from placing a cap on the price of Amgen's blockbuster drug EnbrelSTAT · 25d ago↗ source
- How Butterfly, once known for its handheld ultrasound device, is growing its chip-making businessNvidia got its start as a gaming chip maker before meteoric success selling its chips to nearly every industry. One health tech company is hoping to go down a similar route. Last month, ultrasoun…